首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

全球無標籤陣列系統市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1342879

全球無標籤陣列系統市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Label-free Array Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球無標籤陣列系統市場需求預計將從 2022 年的 47.4 億美元增至 2030 年近 108.5 億美元，2023-2030 年研究期間年複合成長率為 9.64%。

無標記陣列系統是指廣泛用於研究分子相互作用的生物技術鑑定技術。它基於根據生物物理特性對各種分子的識別，以正確分離分子的存在。表面等離子共振 (SPR) 是無標記陣列系統中常用的技術。它具有多種優點，例如快速交付、可靠、可靠和準確等。在準備測定時不需要任何放射性或螢光標記、標籤或專門試劑。它的成本較低，並且提供高水平的資訊。

市場動態：

推動無標記陣列系統市場需求的關鍵因素是對先進系統實現高效藥物發現過程的需求不斷成長。對原子力顯微鏡 (AFM) 及其作為研究腫瘤細胞超微結構和機械特性的高解析度工具的需求不斷成長，導致該市場的需求激增。此外，臨床應用中微懸臂梁需求的增加也推動了該市場的需求。不斷發展的製藥和生物技術公司正在擴大對該市場的需求。此外，技術的不斷進步、研發投資的增加以及醫療保健行業的成長正在增加對該市場的需求。然而，與該技術的儀器相關的高成本可能會阻礙該市場的成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球無標記陣列系統市場的各個細分市場進行了包容性評估。無標記陣列系統行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的無標籤陣列系統市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。無標記陣列系統市場的主要參與者包括 GE Healthcare、Attana AB、Agilent Technologies, Inc.、Danaher Corporation、F. Hoffmann-La Roche AG、Bio-Rad Laboratories、GWC Technologies、PerkinElmer, Inc. 和 BiOptix , Inc.本部分包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望銷售分析
簡介銷售分析
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：無標籤陣列系統公司的競爭格局

無標籤陣列系統市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

十大公司股票分析
市場集中度
GE Healthcare

公司簡介
公司收入
產品
最近的發展

Attana AB

公司簡介
公司收入
產品
最近的發展

Agilent Technologies Inc.

公司簡介
公司收入
產品
最近的發展

Danaher Corporation

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche AG

公司簡介
公司收入
產品
最近的發展

Bio-Rad Laboratories

公司簡介
公司收入
產品
最近的發展

GWC Technologies

公司簡介
公司收入
產品
最近的發展

PerkinElmer Inc.

公司簡介
公司收入
產品
最近的發展

BiOptix Inc.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11219406

The global demand for Label-free Array Systems Market is presumed to reach the market size of nearly USD 10.85 BN by 2030 from USD 4.74 BN in 2022 with a CAGR of 9.64% under the study period 2023 - 2030.

Label-free array system refers to the biotechnological identification technology extensively used to study molecular interaction. It is based on the identification of various molecules depending on the biophysical properties to correctly isolate the molecular presence. Surface plasmon resonance (SPR) is the generally used technique for label-free arrey systems. It provides multiple benefits such as quick delivery, dependability, reliability and accuracy etc. It does not need any radioactive or fluorescent labels, tags or specialized agents in the preparation of assay. It is less expensive along with providing a high level of information.

MARKET DYNAMICS:

The key factor driving the demand for label-free array system market is the increasing demand for advanced systems to achieve productive drug discovery processes. Growing demand for atomic force microscopy (AFM) and its use as a high-resolution tool to study ultrastructure and mechanical characteristics of tumour cells are surging the demand for this market. In addition, the increase in demand for microcantilevers in clinical applications is propelling the demand for this market. The growing pharmaceutical and biotechnology companies are expanding the need for this market. Furthermore, continuous advancement in technology, rise in R&D investments and growth in the healthcare sector are augmenting the demand for this market. However, the high cost associated with the instruments of this technology may hinder the growth of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of label-free array systems. The growth and trends of label-free array systems industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the label-free array systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technique

Surface Plasmon Resonance
Microcantilever
Scanning Kelvin Nanoprobe
Enthalpy Array
Atomic Force Microscopy
Electrochemical Impedance Spectroscopy
Interference-Based Technique
Ellipsometry Technique

By Application

Drug Discovery
Biomolecular Interactions
Detection Of Disease Biomarkers
Others

By End-User

Contract Research Organizations
Academic & Research Institutes
Pharmaceutical & Biotechnology Industries
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Label-free Array Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the label-free array systems market include GE Healthcare, Attana AB, Agilent Technologies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, GWC Technologies, PerkinElmer, Inc., and BiOptix, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . LABEL-FREE ARRAY SYSTEMS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technique
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET ANALYSIS BY TECHNIQUE

6.1 Overview by Technique
6.2 Historical and Forecast Data
6.3 Analysis by Technique
6.4 Surface Plasmon Resonance Historic and Forecast Sales by Regions
6.5 Microcantilever Historic and Forecast Sales by Regions
6.6 Scanning Kelvin Nanoprobe Historic and Forecast Sales by Regions
6.7 Enthalpy Array Historic and Forecast Sales by Regions
6.8 Atomic Force Microscopy Historic and Forecast Sales by Regions
6.9 Electrochemical Impedance Spectroscopy Historic and Forecast Sales by Regions
6.10. Interference-based Technique Historic and Forecast Sales by Regions
6.11 Ellipsometry Technique Historic and Forecast Sales by Regions

7 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Drug Discovery Historic and Forecast Sales by Regions
7.5 Biomolecular Interactions Historic and Forecast Sales by Regions
7.6 Detection Of Disease Biomarkers Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Contract Research Organizations Historic and Forecast Sales by Regions
8.5 Academic & Research Institutes Historic and Forecast Sales by Regions
8.6 Pharmaceutical & Biotechnology Industries Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE LABEL-FREE ARRAY SYSTEMS COMPANIES

10.1. Label-Free Array Systems Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF LABEL-FREE ARRAY SYSTEMS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. GE Healthcare
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Attana AB
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Agilent Technologies Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Danaher Corporation
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. F. Hoffmann-La Roche AG
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Bio-Rad Laboratories
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. GWC Technologies
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. PerkinElmer Inc.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. BiOptix Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments